Week of May 28 - 03, 2017


Feeding Tubes: The Basics

Information about feeding tubes, which are used to supply nutrition when an individual is unable to eat or absorb nutrients through the gastrointestinal (GI) tract.

Midostaurin (Rydapt ®)

Midostaurin (Rydapt ®) is a kinase inhibitor used in the treatment of AML that is FLT3 mutation positive and mast cell leukemia. 

OncoLink at PTCOG

OncoLink coverage of sessions at the 56th Annual Conference of the Particle Therapy Co-operative Group in Japan.

Brigatinib (Alunbrig™)

Brigatinib (Alunbrig ™) is a kinase inhibitor used to treat patients with anaplastic lymphoma kinase (ALK)- positive metastatic non-small cell lung cancer.  

Durvalumab (Imfinzi™)

Durvalumab is a monoclonal antibody, immune therapy used in the treatment of metastatic urothelial cancer.

Niraparib (Zejula™)

Niraparib is a PARP inhibitor used in the treatment of ovarian, fallopian tube, endometrial and primary peritoneal cancers.

Avelumab (Bavenicio ®)

Avelumab (Bavenicio ®) is a programmed death ligand-1 (PD-L1) blocking antibody used in the treatment of Merkel cell carcinoma. 

Telotristat (Xermelo™)

Telotristat (Xermelo™) is a tryptophan hydroxylase inhibitor used to treat diarrhea related to carcinoid syndrome.

Ribociclib (Kisqali®)

Ribociclib (Kisquali®) is used in the treatment of hormone receptor positive, HER2 negative, advanced or metastatic breast cancer in post-menopausal women. 

Blogs

The Conception of OncoLink – A Perspective
by Carolyn Vachani, MSN, RN, AOCN
March 1, 2012

“No Shave November”
by Angelo Melendez
November 10, 2016
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives